Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Jul 19, 2024, 4:00 PM
1.110
-0.030 (-2.63%)
Pre-market: Jul 22, 2024, 8:43 AM EDT
Enzo Biochem Revenue
Enzo Biochem had revenue of $4.72M in the twelve months ending April 30, 2024. Revenue in the quarter ending April 30, 2024 was $8.02M with 7.17% year-over-year growth. In the fiscal year ending July 31, 2023, Enzo Biochem had annual revenue of $31.06M.
Revenue (ttm)
$4.72M
Revenue Growth
-114.73%
P/S Ratio
12.43
Revenue / Employee
$24,847
Employees
190
Market Cap
58.66M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2023 | 31.06M | -1.58M | -4.85% |
Jul 31, 2022 | 32.64M | -85.09M | -72.27% |
Jul 31, 2021 | 117.73M | 41.71M | 54.87% |
Jul 31, 2020 | 76.02M | -5.15M | -6.34% |
Jul 31, 2019 | 81.17M | -19.84M | -19.64% |
Jul 31, 2018 | 101.01M | -4.07M | -3.88% |
Jul 31, 2017 | 105.09M | 2.31M | 2.25% |
Jul 31, 2016 | 102.77M | 5.17M | 5.30% |
Jul 31, 2015 | 97.60M | 1.65M | 1.72% |
Jul 31, 2014 | 95.95M | 2.24M | 2.39% |
Jul 31, 2013 | 93.71M | -9.38M | -9.10% |
Jul 31, 2012 | 103.08M | 1.05M | 1.03% |
Jul 31, 2011 | 102.03M | 4.95M | 5.10% |
Jul 31, 2010 | 97.08M | 7.51M | 8.38% |
Jul 31, 2009 | 89.57M | 11.78M | 15.14% |
Jul 31, 2008 | 77.80M | 24.89M | 47.04% |
Jul 31, 2007 | 52.91M | 13.08M | 32.85% |
Jul 31, 2006 | 39.83M | -3.58M | -8.24% |
Jul 31, 2005 | 43.40M | 1.76M | 4.22% |
Jul 31, 2004 | 41.64M | -11.12M | -21.08% |
Jul 31, 2003 | 52.77M | -1.25M | -2.31% |
Jul 31, 2002 | 54.02M | 1.75M | 3.35% |
Jul 31, 2001 | 52.27M | 9.42M | 21.98% |
Jul 31, 2000 | 42.85M | -1.47M | -3.32% |
Jul 31, 1999 | 44.32M | 3.90M | 9.66% |
Jul 31, 1998 | 40.42M | 5.48M | 15.68% |
Jul 31, 1997 | 34.94M | 448.20K | 1.30% |
Jul 31, 1996 | 34.49M | 2.79M | 8.80% |
Jul 31, 1995 | 31.70M | 9.90M | 45.43% |
Jul 31, 1994 | 21.80M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Rockwell Medical | 86.62M |
Neuronetics | 73.23M |
Cryo-Cell International | 31.64M |
ProPhase Labs | 28.72M |
InspireMD | 6.48M |
Adlai Nortye | 5.00M |
VolitionRx | 797.03K |
ENZ News
- 5 weeks ago - Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments - GlobeNewsWire
- 7 months ago - ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE - GlobeNewsWire
- 9 months ago - Steven J. Pully Appointed to Enzo Biochem's Board of Directors - GlobeNewsWire
- 11 months ago - Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO - GlobeNewsWire
- 1 year ago - Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp - GlobeNewsWire
- 1 year ago - Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results - GlobeNewsWire